CDH5 and retinal disorder: To assess the role of these downstream players in retinopathy, we expanded our studies using mice treated with tamoxifen at P12 to specifically delete TSAd expression in endothelial cells, Sh2d2afl/fl; Cdh5-CreERT2 (denoted Sh2d2a iECKO).